Robert T. Davis Jr. Integra Lifesciences Holdings Corp (IART) insider trading activity

IART Quotes by TradingView

Robert T. Davis Jr. is EVP & President, TT of INTEGRA LIFESCIENCES HOLDINGS CORP. Currently has a direct ownership of 65,107 shares of IART, which is worth approximately $1.44 Million. The most recent transaction as insider was on Mar 12, 2024, when has been sold 2,024 shares (Common Stock) at a price of $35.88 per share, resulting in proceeds of $72,621. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 65.1K
0% 3M change
42.2% 12M change
Total Value Held $1.44 Million

ROBERT T. DAVIS Jr. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 12 2024
SELL
Payment of exercise price or tax liability
$72,621 $35.88 p/Share
2,024 Reduced 3.02%
65,107 Common Stock
Mar 11 2024
SELL
Payment of exercise price or tax liability
$87,290 $36.22 p/Share
2,410 Reduced 4.89%
46,848 Common Stock
Mar 11 2024
BUY
Grant, award, or other acquisition
-
20,283 Added 23.2%
67,131 Common Stock
Mar 10 2024
SELL
Payment of exercise price or tax liability
$23,323 $36.73 p/Share
635 Reduced 1.27%
49,258 Common Stock
Mar 06 2024
SELL
Open market or private sale
$305,453 $36.59 p/Share
8,348 Reduced 14.33%
49,893 Common Stock
Mar 06 2024
BUY
Exercise of conversion of derivative security
$284,706 $32.59 p/Share
8,736 Added 13.04%
58,241 Common Stock
Feb 20 2024
BUY
Grant, award, or other acquisition
-
3,721 Added 6.99%
49,505 Common Stock
Mar 13 2023
SELL
Payment of exercise price or tax liability
$77,284 $52.61 p/Share
1,469 Reduced 3.11%
45,784 Common Stock
Mar 12 2023
SELL
Payment of exercise price or tax liability
$86,548 $52.87 p/Share
1,637 Reduced 3.35%
47,253 Common Stock
Mar 11 2023
SELL
Payment of exercise price or tax liability
$66,457 $52.87 p/Share
1,257 Reduced 2.51%
48,890 Common Stock
Mar 10 2023
BUY
Grant, award, or other acquisition
-
4,227 Added 7.77%
50,147 Common Stock
Mar 01 2023
SELL
Open market or private sale
$86,458 $55.21 p/Share
1,566 Reduced 3.3%
45,920 Common Stock
Mar 01 2023
BUY
Exercise of conversion of derivative security
$42,062 $26.86 p/Share
1,566 Added 3.19%
47,486 Common Stock
Feb 13 2023
BUY
Grant, award, or other acquisition
-
7,108 Added 13.4%
45,920 Common Stock
Mar 13 2022
SELL
Payment of exercise price or tax liability
$164,273 $65.11 p/Share
2,523 Reduced 6.1%
38,812 Common Stock
Mar 12 2022
SELL
Payment of exercise price or tax liability
$133,541 $65.11 p/Share
2,051 Reduced 4.73%
41,335 Common Stock
Mar 11 2022
BUY
Grant, award, or other acquisition
-
7,877 Added 15.37%
43,386 Common Stock
Feb 11 2022
BUY
Grant, award, or other acquisition
-
13,358 Added 27.34%
35,509 Common Stock
Mar 13 2021
SELL
Payment of exercise price or tax liability
$48,079 $68.1 p/Share
706 Reduced 3.09%
22,151 Common Stock
Mar 12 2021
BUY
Grant, award, or other acquisition
-
3,063 Added 11.82%
22,857 Common Stock
Feb 25 2021
SELL
Open market or private sale
$1,732,901 $69.48 p/Share
24,941 Reduced 55.75%
19,794 Common Stock
RTD

Robert T. Davis Jr.

EVP & President, TT
Princeton, NJ

Track Institutional and Insider Activities on IART

Follow INTEGRA LIFESCIENCES HOLDINGS CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IART shares.

Notify only if

Insider Trading

Get notified when an Integra Lifesciences Holdings Corp insider buys or sells IART shares.

Notify only if

News

Receive news related to INTEGRA LIFESCIENCES HOLDINGS CORP

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IART